Skip to main content

Japan-based Softbank to Set Up $120 Million Life Science Fund

NEW YORK, Jan 26 – Tokyo-based Softbank plans to set up a $120 million fund to finance life science companies, a spokeswoman said Friday.

The fund will target companies in the US, Europe, and Asia, beginning in April or May.

Life science companies have much to gain from advances in information technology, said spokeswoman Misao Konishi, citing the role of computing power in the mapping of the human genome.

Softbank has not decided what percentage of the funds will go toward genomics businesses, Konishi said. The fund will invest in both start-ups and more mature companies.

Aozora Bank, which is also in Tokyo, will help finance the project, Konishi said, and other partners are expected to join as the project moves along.

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.